17:06 GMT11 April 2021
Listen Live
    World
    Get short URL
    3201
    Subscribe

    MOSCOW (Sputnik) - The Russian-developed Sputnik V COVID-19 vaccine protects against UK coronavirus variant, and the research on protection against other variants may be available within a week, Alexander Gintsburg, the head of the Gamaleya research institute, said on Tuesday.

    "To date, it has been experimentally verified, including in the laboratories of our institute, that Sputnik V, the serum obtained from those vaccinated with Sputnik V, perfectly neutralises the British version of the pathogen COVID-19", Gintsburg said at a briefing.

    The Gamaleya chief also said that the research on the protection from other coronavirus variants is ongoing, and results may appear within a week or more.

    A medical worker holds a tube with Russian Gam-COVID-VAK (trademark Sputnik V) coronavirus vaccine at a Donetsk clinic, the self-proclaimed Donetsk People's Republic, Eastern Ukraine.
    © Sputnik / Sergey Averin
    A medical worker holds a tube with Russian Gam-COVID-VAK (trademark "Sputnik V") coronavirus vaccine at a Donetsk clinic, the self-proclaimed Donetsk People's Republic, Eastern Ukraine.

    The new strain of coronavirus was discovered in southeast England in September 2020 and emerged in December, prompting a new national lockdown. It subsequently spread rapidly throughout the United Kingdom and continental Europe, as, according to British authorities, it is believed to be up to 70 percent more transmissible than regular coronavirus.

    Tags:
    Russia, United Kingdom, Alexander Gintsburg, Gamaleya Research Institute of Epidemiology and Microbiology, COVID-19, coronavirus, Sputnik V
    Community standardsDiscussion